On October 30, 2024, an event that gathered top medical minds from both domestic and international fields—the WBL Medical Annual Product R&D Discussion Conference and the launch ceremony for the "Science and Innovation China" documentary, along with expert interviews—was grandly held at the Liangjiang Life Science and Technology Industry Park in Chongqing. This event not only marks another significant milestone in WBL Medical's achievements in medical technology innovation but also served as an important opportunity to gather industry elites and collaborate on a healthier future.

The event invited many renowned experts from home and abroad, including Professor Lü Futai from the Department of Urology at the University of California, San Francisco; Dr. Xia Shujie, President of the First Affiliated Hospital of Shanghai Jiao Tong University; Professor Xin Zhongcheng from the First Hospital of Peking University; Dr. Liu Jihong, President of the Tongji Hospital at Huazhong University of Science and Technology; Dr. Li Zheng, President of Bengbu Hospital at Shanghai First People's Hospital; Professor Liang Lili from Peking University First Hospital; and Professor Tan Yan from Shenzhen People's Hospital, among others. These top experts, along with WBL Medical's founder Guo Mao and Professor Guo Yinglu from Peking University, Academician of the Chinese Academy of Sciences, jointly launched a groundbreaking project—the research and application of Low-Intensity Pulsed Ultrasound (LIPUS) technology in the field of men's health.

These authoritative experts worked closely with WBL Medical in the development of LIPUS technology, covering areas such as basic research, animal experiments, and clinical medicine. WBL Medical has always adhered to the core philosophy of "Technology for the People, Innovation for Practical Use," dedicated to transforming cutting-edge technology into practical clinical treatment solutions to provide safer and more effective treatment options for patients. LIPUS technology, as WBL Medical's core technological breakthrough, successfully promotes stem cell aggregation and regeneration through the unique mechanism of low-intensity pulsed ultrasound, offering a new, non-invasive, and highly effective treatment for erectile dysfunction (ED) patients. The birth of this technology not only marks a significant breakthrough for WBL Medical in the field of medical technology innovation but also sets a new benchmark for the global medical community.

The conference began with a dynamic and unique opening, combining speeches and panel discussions to provide a platform for in-depth exchanges and discussions about the future. The experts delivered speeches, sharing their unique insights and extensive experience in the field of medical technology, and engaged in deep discussions with the host. They detailed how, through seven years of theoretical innovation, animal experiments, and clinical validation, they successfully applied LIPUS technology in clinical practice. The wide application of this technology has achieved remarkable results in top-tier hospitals across 16 provinces and cities in China, benefiting millions of patients annually and significantly improving patients' quality of life.

This event was not only an academic exchange feast but also a great gathering to promote technological innovation and explore the life forces of the human body. The experts discussed the innovation and development trends of medical technology and shared their research outcomes and valuable experiences. They all agreed that technological innovation is a key driver of healthcare development and that continuous breakthroughs in technological barriers are essential to providing patients with higher quality and more efficient healthcare services.

As a leader in innovation within China's medical device industry, WBL Medical has successfully promoted technological innovation and development in the urology and andrology sectors with the outstanding performance of LIPUS technology. The company, with its remarkable achievements in technological innovation and clinical applications, has not only gained the trust and praise of many patients but has also become the first medical device high-tech enterprise to be included in the "Science and Innovation China" initiative. This honor fully demonstrates WBL Medical's leadership position and brand value in the industry.

During the conference, Guo Mao, Chairman of WBL Medical, delivered an important speech. He emphasized that the mission of innovative technology lies not only in breaking technological barriers but also in benefiting a wide range of patients and improving their quality of life. In the future, WBL Medical will continue to use technological innovation as its core driving force, increasing investment in research and development, and promoting the continuous improvement and upgrade of LIPUS technology. The company will also actively expand domestic and international markets, strengthen cooperation and communication with international medical institutions, and jointly promote the innovation and development of medical technology.

The successful hosting of this conference not only showcased WBL Medical's outstanding achievements and innovation capabilities in medical technology but also served as an opportunity to build consensus and jointly promote development. The attending experts expressed their intention to use this conference as an opportunity to strengthen exchanges and cooperation, collectively advancing the innovation and development of medical technology and contributing more wisdom and strength to human health. We sincerely thank all the guests for their presence and support and look forward to working together in the future to create a new chapter in medical technology!